Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Rita Jain currently holds 240,000 shares of Akebia Therapeutics, Inc. (AKBA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rita Jain has been a net neutral trader of AKBA stock. They have purchased $0 and sold $0 worth of shares.
Rita Jain's most recent insider trade was on Jan 5, 2026, when they sold 240,000 shares at $0.00 per share.
Rita Jain serves as Executive at Akebia Therapeutics, Inc. (AKBA). They have executed 22 insider transactions totaling $0 over their tenure at the company.
Rita Jain holds the position of Executive at Akebia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Rita Jain has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Rita Jain was on Dec 12, 2018, when they sold $77.4K worth of AKBA shares. This transaction involved 8,659 shares at $8.94 per share.
Rita Jain currently owns 240,000 shares of Akebia Therapeutics, Inc. (AKBA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Rita Jain's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Rita Jain has 22 Form 4 filings on record as an insider at Akebia Therapeutics, Inc..
Set alerts for Rita Jain and 40,000+ other insiders.